Concurrent Workshop A: Navigating the intersection between IP and regulatory exclusivities for protecting and evaluating pharmaceutical, biologic, and medical device products

Go Back

This panel will discuss why IP practitioners should become familiar with regulatory exclusivities and how this knowledge brings value to stakeholders focused on product and business development in the pharmaceutical, biologic, and medical device spaces.  Regulatory and patent exclusivity drive significant value during the product development lifecycle and can be critical factors in patent prosecution strategy and in the evaluation of merger and acquisition, licensing opportunities and/or litigation.  In the commercialization of medical products, regulatory strategy is often inextricably intertwined with other business and legal topics, such as intellectual property protection and competitive intelligence. This panel will discuss, from both a regulatory and IP perspective, how...